| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.06 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.06 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.38 | 0.06 |